Lisa Boggio to Cross-Over Studies
This is a "connection" page, showing publications Lisa Boggio has written about Cross-Over Studies.
Connection Strength
0.037
-
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding. Haemophilia. 2017 Nov; 23(6):832-843.
Score: 0.037